2BB score and signals
Pyxis Oncology, Inc.’s current 2BB score is 15 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 38 | Weak |
| Quality | 80 | Very Strong |
| Risk | 67 | High |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2018 |
| Employees | 56 |
| 52-week range | $1.03 – $5.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-22 | — | -0.2743 | — | $22,317.00 |
| 2026-11-02 | — | -0.2926 | — | $0.00 |
| 2026-08-19 | — | -0.3604 | — | $22,317.00 |
| 2026-05-14 | -0.37 | -0.3763 | $0.00 | $0.00 |
Related companies
